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Background. Features that may allow early identification of patients at risk of prolonged delirium, and therefore of poorer outcomes,
are not well understood. The aim of this study was to determine if preoperative delirium risk factors and delirium symptoms (at
onset and clinical symptomatology during the course of delirium) are associated with delirium duration.Methods. This study was
conducted in prospectively identified cases of incident delirium. We compared patients experiencing delirium of short duration (1
or 2 days) with patients who had more prolonged delirium (≥3 days) with regard to DRS-R-98 (Delirium Rating Scale Revised-
98) symptoms on the first delirious day. Delirium symptom profile was evaluated daily during the delirium course. Results. In a
homogenous population of 51 elderly hip-surgery patients, we found that the severity of individual delirium symptoms on the first
day of deliriumwas not associated with duration of delirium. Preexisting cognitive decline was associated with prolonged delirium.
Longitudinal analysis using the generalised estimating equations method (GEE) identified that more severe impairment of long-
termmemory across the whole delirium episode was associated with longer duration of delirium.Conclusion. Preexisting cognitive
decline rather than severity of individual delirium symptoms at onset is strongly associated with delirium duration.
1. Introduction
Postoperative delirium is a common complication in elderly
hip-fracture patients, that is associated with high mortal-
ity, cognitive deterioration, and a high rate of subsequent
institutionalization [1–3]. Delirium follows a variable course,
ranging from a brief transient state to more persistent illness
that can evolve into long-term cognitive impairment [4,
5]. Factors that may allow earlier identification of patients
who are at risk of more prolonged delirium are not well
understood [6, 7]. Although studies over the past decade
have improved our understanding of the phenomenology
of delirium, little is known about the association between
specific delirium symptoms and duration of delirium [8].
Few studies have examined delirium symptoms as a risk
factor for an extended duration of the delirious episode. Pre-
vious studies have used the Delirium Rating Scale (DRS) [9]
to measure the severity of delirium symptoms [10, 11]. Rud-
berg et al. (1997) found that patients experiencing delirium
of a single day’s duration did not differ from more persistent
(multiple days) cases with regard to individual DRS item
scores on the first day of delirium [10]. Conversely, Wada and
Yamaguchi (1993), who also used the DRS, found that more
severe cognitive impairment, sleep-wake cycle disturbances,
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and mood lability were associated with longer delirium
episodes (>1 week versus ≤1 week) [11]. However, these
studies used the original DRS which focuses upon a relatively
narrow range of delirium symptoms compared to the revised
version (DRS-R-98) and/or did not control for factors such as
preexisting cognitive problems, including dementia. This is a
significant shortcoming of previous research since dementia
may be a predictor of illness duration [12, 13], in addition to
being an important risk factor for delirium [14].
Most studies that investigated delirium duration re-
stricted delirium monitoring to specific time intervals. The
risk of mortality is increased by 11% for every additional 48
hours that delirium persists [15]. This makes it imperative
to gain more insight into the determinants of delirium
duration.Moreover, frequent (e.g., daily) assessmentsmake it
possible to determine that the character of delirium is related
to episode duration.
In this prospective observational study we investigated a
homogenous cohort of elderly hip-surgery patients aged 75
or older, who were carefully monitored on a daily basis for
the occurrence of delirium.The aim of the present study was
to identify patient characteristics that are associatedwith pro-
longed delirium and explore how delirium symptomatology
evolves over time.
2. Methods
2.1. Ethical Considerations. The study was undertaken in
accordance with the Declaration of Helsinki and the guide-
lines on Good Clinical Practice. Approval of the regional
research ethics committee was obtained. Patients or their
relatives gave fully informed written consent.
2.2. Study Design and Objectives. This was a prospective
cohort study in elderly hip-fracture patients. Evaluating the
relationship between patient characteristics and deliriumwas
a prespecified aim of this study.
Patient characteristics and risk factors for delirium were
assessed preoperatively. Presence and severity of delirium
were assessed daily. Since all participants were at high risk
for delirium (i.e., age 75 years or older, and acute hospital
admission), all patients received routine care with prophylac-
tic treatment of 0.5mg haloperidol, three times daily, from
time of admission until postoperative day three, unless con-
traindications regarding its use were present [16].
We investigated the association between delirium symp-
toms on the first delirious day, with subsequent duration of
the delirious episode. We compared incident delirium cases
experiencing short delirium episodes (1 or 2 days) with
patients who experienced more prolonged delirium (≥3
days). Thereafter, we investigated the association between
delirium symptom profile over time and duration in days
until recovery. For this longitudinal analysis, data on DRS-
R-98 item scores gathered over all days of active deliriumwas
included.
2.3. Participants. The study was conducted in a series of con-
secutively admitted elderly hip-fracture patients to a teaching
hospital in Alkmaar,TheNetherlands. Eligibility was checked
for all patients 75 years and older admitted for primary
surgical repair of hip fracture. From March 2008 to March
2009, 192 hip-fracture patients were eligible, and they fulfilled
criteria for participation and provided consent. A subgroup of
this study cohort, 122 patients, also participated in a clinical
trial that compared the effectiveness of taurine versus placebo
in reducing morbidity and one-year mortality in elderly
hip fracture patients (Clinicaltrials.gov; registration number
NCT00497978; this project has been the subject of a previous
report [17]). The 122 patients who participated in the RCT
were younger compared to the rest of the 192 eligible patients.
Patients were ineligible to participate in the study if they
had no surgery, had amalignancy, had a previous hip fracture
on the identical side, were in contact isolation, incapable of
participating in interviews (language barrier, aphasia, and
coma), had no acute trauma, were transferred to another
hospital, or received a total hip prosthesis.
For the current analysis we also excluded cases who died
during hospitalization, were already delirious before surgery
or could not be allocated to one of the duration groups
according to the definition of recovery. The people who died
during admission were more oftenmale, had a history of pre-
vious delirium, and were more dependent in their activities
of daily living compared to the rest of the 192 eligible
patients. Preoperative delirium cases were excluded because
we focused upon a well-defined homogeneous group of
incident delirium, and the presence of preoperative delirium
includes cases where delirium may have contributed to falls
and need for subsequent hip-fracture surgery. Patients with
no data available on the two days after the last delirious day
could not be allocated to one of the duration groups. In this
instance we could not define the exact count of delirious days
according to the definition used for recovery.
2.4. Measurements and Procedures
2.4.1. Baseline Assessment. Baseline assessment was com-
pleted within 12 hours of admission and prior to surgery.
This comprised delirium assessment, patient and proxy
interviews and questionnaires, and inspection of the medical
record to assess for risk factors for delirium. Preoperative
cognitive functioning was assessed with the Mini-Mental
State Examination (MMSE) on a scale of 0 to 30 with scores
lower than 24 indicating cognitive impairment [18]. Prefrac-
ture cognitive decline was estimated with the short version
of the Informant Questionnaire on Cognitive Decline in the
Elderly (IQCODE-N), scored by a close relative or caregiver.
This measures preexisting cognitive decline during the past
10 years on a scale of 16 (improvement) to 70 (decline) [19].
A total score higher than 57 (i.e., a mean item-score higher
than 3.6) indicates cognitive decline [20]. For the IQCODE-
N proxies were asked to describe the patient’s condition a
week before the fracture as to determine function unbiased
by the event of hip fracture itself or any acute or subacute
event leading to hip fracture. Burden of illness included the
number and type of medical comorbidities and medications
before hospital admission. Demographic factors included age
and gender. Data on medication was collected as part of
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the prospective data collection and checked again afterwards
by medical record review. We also reviewed medical records
to document the Acute Physiology Age and Chronic Health
Examination (APACHE II) score (range of 0 (no acute health
problems) to 70 (severe acute health problems)) [21]. Fun-
ctional status comprised prefracture living arrangement,
visual acuity, activities of daily living (ADL), and instrumen-
tal activities of daily living (IADL). Visual acuity was assessed
with the standardized Snellen test for visual impairment [22],
and visual impairment was defined as binocular near vision,
after correction, worse than 20/70. Prefracture ADL func-
tioning was determined with the Barthel Index (BI) which
is scored by a close relative or caregiver on a scale from
0 (dependence) to 20 (independence) [23]. IADL was also
assessed by a close relative or caregiver on the Lawton IADL
scale with a range of 8 (no disability) to 31 (severe disability)
[24].
2.4.2. Outcome. The primary outcome was duration of deli-
rium. The highly fluctuating nature of delirium makes for
problems in reliably defining recovery, and therefore a stan-
dard definition is lacking [25]. We followed a conservative
approach to define recovery of delirium as two subsequent
days without delirium according to the Confusion Assess-
ment Method (CAM) [26]. For some analyses (specified in
what follows) delirium duration was used as a continuous
variable, whereas we also used a dichotomy with incident
cases who were delirious for 1 or 2 days labeled as “short
delirium” with the remaining cases who were delirious for
three days or more, labeled as prolonged delirium. A single
day without delirium but followed by further delirium was
considered part of the delirium episode.
Deliriumwas defined according to the Confusion Assess-
ment Method (CAM) and validated with a diagnosis based
on DSM IV criteria [26, 27].The CAM consists of acute onset
and fluctuating course of cognitive function, inattention, and
either disorganized thinking and/or altered level of cons-
ciousness. Delirium severity was measured using the Delir-
ium Rating Scale Revised-98 (DRS-R-98), a 16-item rating
scale comprised of thirteen severity items and 3 diagnostic
items. The item scores have range of 0 (no severity) to 3
(maximum severity). Possible total severity scores have range
of 0 (no severity) to 39 (maximum severity) [28]. Presence
and severity of delirium were assessed within 12 hours after
admission and before surgery and continued daily after
deliriumonset or until the fifthpostoperative day for delirium
onset. Delirium usually presents itself within the first few
days after surgery, if delirium onset is after this time frame
it is mostly caused by secondary complications (e.g., uri-
nary tract infection) [29–34]. The CAM and DRS-R-98
rating were based on all available information, collected by
trained research assistants, including (i) brief formal cogni-
tive testing with the MMSE, (ii) patient and hospital staff
interviews, and (iii) scrutiny of the medical and nursing
records.
2.5. Data Analysis. Data analysis was performed using
SPSS for Windows, version 19 (SPSS, Inc., Chicago, Il).
Comparisons of group characteristics were made using chi-
square or Fisher’s exact test for differences in proportions, t-
testing for differences in means, and nonparametric tests for
rank differences.
The univariate significant baseline variables between the
short and prolonged delirium group were analyzed with
binary logistic regression using the backward Wald method,
in order to select the control variables for the first and second
part of the research question.
For the first research question (the prediction of short
versus prolonged delirium duration by the initial severity of
DRS-R-98 items and baseline characteristics) binary logistic
regression with the backward Wald method was used. Delir-
ium duration was the binary-dependent variable (short (≤2
days) versus long (≥3 days)).
At first we applied a logistic regression model with only
the scores (range 0 to 3) on the 13 DRS-R-98 severity items
on the first day of delirium. Afterwards the same model
was repeated but including the covariates: age, sex, and
prior cognitive decline (IQCODE > 3.6). The variables were
checked for collinearity (collinearity statistics, tolerance, and
variance inflation factor (VIF) were performed; all variables
entered into the model had a VIF less than 10 and Tolerance
more than 0.1).
For the second research question (clinical symptomatol-
ogy during the course of delirium) a generalised estimating
equations model was used to analyze longitudinal data for
patterns of individual items from the DRS-R-98 (items 1–13)
between cases with different delirium duration until recovery
(range from 1 through 9 days). All available DRS-R-98 item
scores (1–13) from first day of delirium until the defined
end of the delirium episode were included as independent
variables. The continuous dependent variable was duration,
measured as the sum of the delirium days from the first day
of delirium until the end of delirium. Because it is factually
a count variable, following a Poisson distribution, we treated
this as such.The GEEmethod takes into account the fact that
observations within a subject are correlated and estimates the
population average across time. All scale items were included
in each analysis although only those that were significantly
different are shown in the results tables.
Results were classified as significant if the𝑃 value was less
than 0.05.
3. Results
After excluding ineligible patients (𝑛 = 73), patients who died
in hospital (𝑛 = 12), and prevalent cases (𝑛 = 23) there
were 57/157 (36.3%) incident delirium cases (Figure 1). Six
cases were excluded, since they could not be defined with
certainty as belonging to the short or prolonged delirium
group because of missing data. The second research question
involved exclusion of another 8 cases because of missing
data that impeded determining exact duration of delirium
according to our definition of recovery. Treatment (taurine
or placebo) had no effect on daily CAM diagnosis, DRS-R-98
total scores, and delirium duration, so this was not entered
as a control variable in further analysis. Logistic regression
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Eligible patients
(n = 192)
Patients (n = 157)
Never delirious (n = 100)
Incident delirium (n = 57)
Prevalent delirium (n = 23)
Patients (n = 180)
Original study
Patients admitted
(n = 265)
Patients not meeting inclusion criteria (n = 73)
Discharged without surgery (n = 16)
Previous identical hip fracture (n = 6)
Malignancy (n = 2)
Transfer to another hospital (n = 6)
Total hip prosthesis (n = 4)
No acute trauma (n = 9)
Not testable (n = 15)
Missed by emergency department (n = 6)
Refused to participate (n = 8)
Contact isolation (n = 1)
Died during admission (n = 12)
Definition: short versus prolonged delirium
(n = 51)
Short delirium (1–2 days) (n = 22)
Prolonged delirium (≥ 3 days) (n = 29)
Definition: count delirium days until recovery
(n = 42)
1 day = 12
2 days = 10
3 days = 6
4 days = 4
5 days = 3
6 days = 3
7 days = 1
8 days = 1
9 days = 2
Figure 1: Flow diagram of the study.
analysis with baseline characteristics identified IQCODE
score > 3.6 as the only significant factor, so this was entered
as a control variable in further analysis.
The average age of the 13 male and 38 female patients
was 85.1 ± 5.4 (mean ± standard deviation). A total of 22/51
cases (43.1%) had short delirium (1 or 2 days) and 29/51
cases (56.9%) had prolonged delirium (≥3 days). Within the
prolonged delirium 20/28 cases could be further defined with
regard to exact duration (3 days: 𝑛 = 6; 4 days; 𝑛 = 4; 5 days,
𝑛 = 3; 6 days: 𝑛 = 3; 7 days: 𝑛 = 1; 8 days: 𝑛 = 1 and 9 days:
𝑛 = 2). A significantly greater (𝑃 = 0.003) proportion of
patients within the prolonged delirium group (26/29 cases:
89.7%) compared to the short delirium group 11/22 cases
(50%) had an IQCODE > 3.6. A further comparison of the
short and prolonged delirium group on other variables is
depicted in Table 1. The use (yes or no) of medication classes
(sedative hypnotics, antipsychotics, opioids, beta-blocking
agents, antidepressants, antihistamines for systemic use, anti-
parkinson agents, corticosteroids for systemic use, nonster-
oidal anti-inflammatory agents, antiepileptics, diuretics, and
H
2
-antagonists did not differ significantly between the short
and prolonged delirium group.
Table 2 shows a descriptive analysis of the presence (score
≥1) of delirium symptoms within the short and prolonged
delirium group on the first day. Disturbed orientation and
attention were prominent features in both groups. Only
visuospatial functioning differed significantly (OR 5.3, 95%
CI 1.28–21.57, 𝑃 = 0.02).
Figure 2 displays the mean scores on DRS-R-98 items
on the first day of delirium within the short and prolonged
delirium groups. None of the individual item scores differed
significantly between the groups.
Logistic regression analysis indicated that more severe
motor retardation on the DRS-R-98 was associated with pro-
longed delirium (OR 1.88, 95% CI 1.03–3.42, 𝑃 = 0.04). The
model’s𝑅2 (Nagelkerke) was 0.16, and percentage of correctly
classified patients was 61.5% (1-2 days: 0%, ≥3 days: 100%).
After controlling for time-invariant variables (gender,
age, and preexistent cognitive decline) none of the DRS-R-98
items on the first day of delirium were associated with delir-
iumduration.Only preexistent cognitive decline (IQCODE>
3.6) was associated with prolonged delirium (OR 0.1, 95% CI
0.02–0.61, 𝑃 = 0.01). The model’s 𝑅2 (Nagelkerke) was 0.24,
and the overall percentage of correctly classified patients was
74.4% (1-2 days: 46.7%, ≥3 days: 91, 7%).
The longitudinal analysis with data on DRS-R-98 item
scores gathered over all the delirium days gave the final
most parsimonious GEEmodel (113 observations, 38 patients
included) that is shown in Table 3. A higher score on long-
term memory (DRS-R-98 item 12) was associated with a
longer duration of delirium until recovery considering all
assessments within the delirium episode.
4. Discussion
This study is one of the few to describe the predictive
value of delirium symptomatology in the early phase of the
delirium episode for subsequent duration. In a homogenous
population of elderly hip-surgery patients, we found that the
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Table 1: Baseline clinical and demographic characteristics of patients in the short and prolonged delirium group.
Characteristic Short delirium Prolonged delirium OR (95% CI) 𝑃 value
𝑛 = 22 𝑛 = 29
Age∗ 84.6 ± 4.7 85.6 ± 5.9 1.04 (0.93–1.15) 0.50
Female∘ 17 (77.3) 21 (72.4) 1.30 (0.36–4.69) 0.69
Mini-Mental State Examination (MMSE) score∗¶ 23.0 ± 3.1 19.6 ± 5.5 0.84 (0.71–0.99) 0.02
APACHE II score∗§ 13.3 ± 3.0 13.9 ± 3.1 1.14 (0.87–1.49) 0.34
Snellen test∗ 31.6 ± 18.1 38.6 ± 35.5 1.01 (0.98–1.04) 0.41
Barthel ADL Index score∗△ 17.4 ± 3.0 14.0 ± 4.1 0.76 (0.62–0.93) 0.003
Lawton IADL score∗≈ 14.8 ± 5.8 18.6 ± 8.3 1.08 (0.99–1.17) 0.08
Geriatric Depression Scale-15 score∗† 6.4 ± 1.1 6.4 ± 1.7 0.98 (0.61–1.59) 0.95
CRP value∗ 12.7 ± 25.2 13.4 ± 28.5 1.00 (0.98–1.02) 0.76
History of previous delirium∘ 0 (0) 12 (46.2) N.A. 0.001
IQCODE-N > 3.6∘ 11 (50) 26 (89.7) 8.7 (2.02–37.26) 0.002
Number of concomitant diseases at admission∗ 2.4 ± 1.5 3.2 ± 2.5 1.20 (0.90–1.60) 0.18
Number of medication at admission∗ 4.2 ± 2.4 5.6 ± 3.8 1.15 (0.95–1.38) 0.12
MMSE score on the first day of delirium∗¶ 18.1 ± 6.3 15.1 ± 6.0 0.92 (0.83–1.03) 0.13
¥DRS-R-98 score on the first day of delirium∗ 18.6 ± 6.4 20.6 ± 6.5 1.05 (0.96–1.15) 0.28
Data are presented as mean ± SD or 𝑛 (%) unless otherwise indicated.
∗Continuous variables, ∘dichotomous variables.
OR: odds ratio, the chance of developing prolonged delirium, CI: confidence interval.
APACHE II: Acute Physiological and Chronic Health Evaluation II.
IQCODE-N: Informant Questionnaire on Cognitive Decline in the Elderly, >3.6 indicates preexistent cognitive decline.
DRS-R-98: Delirium Rating Scale Revised-98.
¶Range 0 (severe cognitive impairment) to 30 (no cognitive impairment).
§Range 0 (no acute health problems) to 70 (severe acute health problems).
△Range 0 (severe disability) to 20 (no disability).
≈Range 8 (no disability) to 31 (severe disability).
†Range 0 (depression not likely) to 15 (depression very likely).
¥Range 0 (no delirium symptoms) to 39 (maximum severity).
Table 2: Presence of individual DRS-R-98 delirium symptoms on first day of delirium.
DRS-R-98 item Short delirium (𝑛 = 22) Prolonged delirium (𝑛 = 29) 𝑃 value
(1) Sleep-wake cycle disturbance 21 (95.5%) 29 (100%) 0.43
(2) Perceptual disturbances and hallucinations 8/21 (38.1%) 13/27 (48.1%) 0.49
(3) Delusions 11/21 (52.4%) 14/27 (51.9%) 0.97
(4) Affective lability 15 (68.2%) 15/28 (53.6%) 0.30
(5) Language problems 18 (81.8%) 22 (75.9%) 0.74
(6) Thought process abnormalities 19 (86.4%) 27 (93.1%) 0.64
(7) Motor agitation 14 (63.6%) 20 (69%) 0.69
(8) Motor retardation 11/21 (52.4%) 20 (69%) 0.23
(9) Orientation problems 22 (100%) 28 (96.6%) 1.00
(10) Attention deficits 22 (100%) 28 (96.6%) 1.00
(11) Short-term memory impairment 20/21 (95.2%) 27/28 (96.4%) 1.00
(12) Long-term memory impairment 12/18 (66.7%) 22/28 (78.6%) 0.37
(13) Visuospatial impairment 9/18 (50%) 21/25 (84%) 0.02
Data are presented as 𝑛 (%) or 𝑛/𝑛 (%) in case of missing data.
severity of individual delirium symptoms at the first day of
deliriumwas not associatedwith short or prolonged delirium.
Initially motor retardation was identified as a predictor for
longer delirium duration (≥3 days), but when controlling for
gender, age, and preexisting cognitive decline, only preex-
isting cognitive impairment was associated with prolonged
delirium. In addition more severe impairment of long-term
memory (as it was also measured with DRS-98 R item 12)
across the whole delirium episode was associated with longer
duration of delirium.
Preexisting cognitive impairment is thought to be more
common in hypoactive delirium, although there is quite
limited data to support this observation [35]. Our data
indicate that the observed relationship between relatively
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Table 3: Generalised equation estimation (GEE) model for DRS items 1–13 for different lengths of delirium episodes until recovery (count of
days).𝑁 = 113 included observations.
𝛽 SE df Wald 𝜒2 95% CI 𝑃
DRS-R-98 item 6
Thought process abnormalities
−7.9𝐸 − 6 6.30𝐸 − 6 1 1.558 −2.03𝐸 − 5, 4.5𝐸 − 6 0.21
DRS-R-98 item 9
Orientation
−6𝐸 − 6 8.88𝐸 − 6 1 0.456 −2.34𝐸 − 5, 1.14𝐸 − 5 0.50
DRS-R-98 item 10
Attention
−5.17𝐸 − 6 8.83𝐸 − 6 1 0.343 −2.25𝐸 − 5, 1.21𝐸 − 5 0.56
DRS-R-98 item 11
Short-term memory
−1.08𝐸 − 6 9.67𝐸 − 6 1 0.012 −2.01𝐸 − 5, 1.79𝐸 − 5 0.91
DRS-R-98 item 12
Long-term memory
1.45𝐸 − 5 7.20𝐸 − 6 1 4.044 3.67𝐸 − 7, 2.86𝐸 − 5 0.04
DRS-R-98 item 13
Visuospatial impairment
8.86𝐸 − 6 1.16𝐸 − 5 1 0.580 −1.40𝐸 − 5, 3.17𝐸 − 5 0.45
Constant 1.21 0.11 1 119.487 0.99, 1.42 0.000
SE: standard error, C.I.: confidence interval, 𝐸 with a minus sign signals the number of places the decimal point has to be moved to the left.
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Figure 2: Mean DRS-R-98 item scores for short (1-2 days) versus prolonged (≥3 days) delirium on the first delirious day.
hypoactive clinical profile (asmeasured on item 8 of theDRS-
R98) and more prolonged delirium is confounded by the
relationship between motor retardation and preexisting cog-
nitive impairment. This observation supports clinical expe-
rience where delirium superimposed on dementia is more
likely to be hypoactive and resolves more slowly.
There have been few studies investigating the predictive
value of delirium symptoms on the first day of delirium, and
findings have been inconsistent. Rudberg et al. (1997) deter-
mined the durationwithin amixed sample of 64 generalmed-
ical and surgical patients who were found to have delirium
[10]. Similar to our findings, there was no difference between
delirium lasting a single day versus that of more prolonged
cases in relation to individual delirium symptoms. They did
find that the multiple day cases had higher DRS total scores
on the first day. In contrast, Wada and Yamaguchi [11] found
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that poor cognitive status, sleep-wake cycle disturbances, and
mood labilitywere associatedwith delirium lastingmore than
a week. However, in our study item 12 (long term mem-
ory) was the only predictive item from DRS-R-98 for deli-
rium duration such that participants with more severe long-
term memory problems experienced more prolonged deli-
rium. However, the two previously mentioned studies mea-
sured symptoms with the original 10-item DRS, which
includes amore restricted range of symptoms than the revised
DRS-R-98 which captures a wider range of cognitive and
neuropsychiatric disturbances that occur in delirium and is
widely used in the assessment of delirium severity and in
phenomenological studies. In addition, both patient popu-
lations were highly heterogeneous and not only limited to
only postoperative delirium and focused only on univariate
analysis without controlling for confounding factors, like pre-
existing cognitive decline.
The study by Wada and Yamaguchi described delirium
duration according to a general category (≤1 week versus >1
week) [11].However, we found that almost half of the delirious
patients experienced a delirium episode of 1 to 2 days.
Rudberg et al. also found a high percentage of cases (69%)
with a single day of delirium in their sample [10]. Recent
work has highlighted the impact of short periods of delirium
upon outcomes and emphasises the importance of daily
assessments in studies of delirium [15].
Ourwork includes some significant strengths that include
the use of daily measurements with the DRS-R-98. Moreover,
given the challenges in longitudinal studies of handling the
effects of dropouts, interdependence of ratings across visits
within patients, and individual patient variability in delirium
severity over time, we used the GEE modeling method
because it manages these issues in longitudinal datasets and
is therefore particularly suited to investigating the course of
delirium, considering its fluctuating nature.
Preexisting cognitive decline is thought to be associated
withmore prolonged delirium. It has been postulated that this
reflects the effects of uncontrolled neuroinflammation con-
tributing to delirium symptoms [36]. Experimental findings
and neuropathological observations suggest that activation of
microglia is pivotal for mediation of the acute behavioural
and cognitive effects of systemic inflammation [36]. A mild
systemic inflammatory response suffices to increase the pro-
duction of proinflammatory cytokines within the brain when
microglia are already “primed” by chronic pathologic events
as chronic neurodegeneration or advanced age [37]. After hip
surgery the release of pro-inflammatory cytokines as a con-
sequence of fracture and surgery induces a systemic inflam-
matory response. Since inflammatory markers have been
shown to be elevated in dementia as well as MCI [38–40], it
follows that preexisting cognitive impairment might not only
increase the chance of developing delirium but also prolong
it.
This work also has some limitations. The present study
was naturalistic in design. Patients received optimal care,
which incorporates extensive general geriatric care and halo-
peridol as prophylactic interventions in high risk patients and
delirium treatment according to study site protocol. Both
are known to impact positively upon the course of delirium.
Although we cannot exclude the effect haloperidol might
have had on motor symptom profile in this population, simi-
lar longitudinal work in a palliative care setting suggests a
limited relationship between motor activity and use of anti-
psychotic agents [41]. Furthermore, since all patients in our
sample were of high risk for delirium and thus all received
haloperidol prophylaxis, any likely effects would be likely
similar for all the patients in our sample. Although a sub-
sample of the patients participated in a clinical trial, analysis
showed that study treatment (taurine/placebo) did not have
effect on study outcomes. Also, delirium treatment was deliv-
ered according to a standard protocol, and this did not differ
between the sample participating in the clinical trial and the
naturalistic cohort.
The exclusion of participants who could not be classified
regarding the duration of delirium episode might reduce the
strength of this study. This study is not the first to define
two consecutive negative delirium assessments as resolution
of the delirium episode [42]. However, to allow for greater
confidence, we repeated the analysis twice. First, the analysis
was repeated with the excluded patients added to the short
delirium group, because we had data of at least 1 or 2 delirious
days. Second, the prolonged delirium group was limited to
patients who could be exactly defined according to duration
of the delirium episode in exact count of days, similar to the
short delirium group. This did not change the results evident
in the initial analysis.
This study excluded preoperative delirium cases and
focused upon incident delirium cases, a well-defined and
homogeneous group of elderly hip-fracture patients. Preop-
erative delirium cases might have experienced hip fracture
because of their confusion and subsequent other causes.
Lee et al. (2011) demonstrated that delirium duration can last
as long as 4 weeks or longer [13]. The main cause of this pro-
longed delirium was preoperative delirium. The duration of
delirium has been noted to be shorter, suggesting that pre-
operative delirium may include a different group who war-
rants separate study.
The sample size was relatively small as it was limited to
incident cases of delirium. The main finding that cognition
rather than delirium profile is associated with delirium dura-
tion was demonstrated by two separate methods. The GEE
method is an innovative statistical analysis used for longitu-
dinal data analysis, and the small sample size is less important
with this analysis because we have a relative large number of
observations due to the use of daily assessments.
In conclusion, this study explores the relationship
between baseline status and early symptoms of delirium with
delirium duration in a homogenous population using val-
idated measurement scales. Preexisting cognitive decline,
a concept intertwined with dementia, rather than specific
delirium symptoms, was the principal predictor of delirium
duration.
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